semaglutide and the heart Weight loss drug's benefits extend to people with heart failure | UCL News Semaglutide Shows Secondary Cardiovascular Prevention

"The type of study conducted here helps identify potential links between GLP-1 treatment and NAION, but its not the type of study that can show the treatment caused NAION, states Andrew Lee, MD, a clinical spokesperson for the American Academy of Ophthalmology and a neuro-ophthalmologist at Houston Methodist Hospital, in a recent Vision Monday article

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Homma T, Kobayashi S, Fujii J

Sources: STEP 1 Trial, Wegovy prescribing information, Novo Nordisk

What was once a relatively low-visibility area of pharmaceutical law quickly became one of the most actively enforced spaces in healthcare regulation